07:00 , Sep 23, 2010 |  BC Innovations  |  Distillery Techniques

Technology: Markers

Approach Summary Licensing status Publication and contact information Markers Immunohistochemical characterization of medulloblastomas based on dickkopf homolog 1 (DKK1), secreted frizzled-related protein 1 (SFRP1), natriuretic peptide receptor C/guanylate cyclase C (NPR3) and potassium channel Kv1.1...
08:00 , Jan 22, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Musculoskeletal disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Osteoporosis Secreted frizzled related protein-1 (SFRP1) SAR studies identified diphenylsulfone sulfonamide derivatives as SFRP1 inhibitors that could be useful for...
08:00 , Jan 22, 2009 |  BC Innovations  |  Distillery Therapeutics

Indication: Musculoskeletal disease

This week in therapeutics Indication Target/marker/pathway Summary Licensing status Publication and contact information Musculoskeletal disease Osteoporosis Secreted frizzled related protein-1 (SFRP1) An ex vivo assay suggests that SFRP1 inhibitors may be useful for treating osteoporosis....
07:00 , May 13, 2002 |  BC Week In Review  |  Company News

Johns Hopkins University School of Medicine other research news

Researchers published in Nature Genetics a microarray-based method for identifying promoter regions of genes that are controlled by methylation and/or histone deacetylase (HDAC) activity. As proof of concept, the researchers used the process to identify...